Andreassen, C. N., Rosenstein, B. S., Kerns, S. L., Ostrer, H., De Ruysscher, D., Cesaretti, J. A., Barnett, G. C., Dunning, A. M., Dorling, L., West, C. M., Burnet, N. G., Elliott, R., Coles, C., Hall, E., Fachal, L., Vega, A., Gómez-Caamaño, A., Talbot, C. J., Symonds, R. P., De Ruyck, K., Thierens, H., Ost, P., Chang-Claude, J., Seibold, P., Popanda, O., Overgaard, M., Dearnaley, D., Sydes, M. R., Azria, D., Koch, C. A., Parliament, M., Blackshaw, M., Sia, M., Fuentes-Raspall, M. J., Ramon y Cajal, T., Barnadas, A., Vesprini, D., Gutiérrez-Enríquez, S., Mollà, M., Díez, O., Yarnold, J. R., Overgaard, J., Bentzen, S. M., Alsner, J., & , (n.d.). individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiotherapy and oncology, 121(3), 431–439. http://access.bl.uk/ark:/81055/vdc_100054679784.0x00003d